Skeletal Effects of Phytoestrogens: Rodent Models:Diet

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Unknown venue

• Publication date

  2002-06-30

• Fields of study

  Biology, Agricultural and Food Sciences, Medicine

• Identifiers
  DOI 10.1201/9781439822197.CH7
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Cross-cultural association between dietary animal protein and hip fracture: A hypothesis

  2004cited by this paper
• Dried Plums Improve Indices of Bone Formation in Postmenopausal Women

  2002cited by this paper
• A nonhuman primate model of age-related bone loss: a longitudinal study in male and premenopausal female rhesus monkeys.

  2001cited by this paper
• Soy isoflavone supplementation in postmenopausal women. Effects on plasma lipids, antioxidant enzyme activities and bone density.

  2001cited by this paper
• Effects on menopausal symptoms and acceptability of isoflavone-containing soy powder dietary supplementation

  2001cited by this paper
• Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials.

  2001cited by this paper
• Soybean isoflavones dose-dependently reduce bone turnover but do not reverse established osteopenia in adult ovariectomized rats.

  2001cited by this paper
• Wheat bran and soy protein feeding do not alter urinary excretion of the isoflavan equol in premenopausal women.

  2001cited by this paper
• Dose-dependent bone-sparing effects of dietary isoflavones in the ovariectomised rat

  2001cited by this paper
• Male rodent model of age-related bone loss in men.

  2001cited by this paper
• Soy Intake and the Maintenance of Peak Bone Mass in Hong Kong Chinese Women

  2001cited by this paper
• The effect of isoflavones extracted from red clover (Rimostil) on lipid and bone metabolism

  2001cited by this paper
• Dietary inclusion of whole soy foods results in significant reductions in clinical risk factors for osteoporosis and cardiovascular disease in normal postmenopausal women

  2001cited by this paper
• Nonhuman primate models in skeletal research.

  2001cited by this paper
• Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease.

  2001cited by this paper
• Soy Intake Related to Menopausal Symptoms, Serum Lipids, and Bone Mineral Density in Postmenopausal Japanese Women

  2001cited by this paper
• The Role of Phytoestrogens in the Prevention and Treatment of Osteoporosis in Ovarian Hormone Deficiency

  2001cited by this paper
• Exposure to Flaxseed and its Purified Lignan Reduces Bone Strength in Young but Not Older Male Rats

  2001cited by this paper
• Soy for breast cancer survivors: a critical review of the literature.

  2001cited by this paper
• Osteoporosis prevention, diagnosis, and therapy.

  2001cited by this paper
• Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements.

  2001cited by this paper
• Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment.

  2001cited by this paper
• Role of soy diet and L-arginine in cyclosporin-A-induced osteopenia in rats.

  2001cited by this paper
• Exposure to purified lignan from flaxseed (Linum usitatissimum) alters bone development in female rats

  2001cited by this paper
• Soy Isoflavones—Benefits and Risks from Nature’s Selective Estrogen Receptor Modulators (SERMs)

  2001cited by this paper
• Reductionism and the narrowing nutrition perspective: time for reevaluation and emphasis on food synergy.

  2001cited by this paper
• The Use of Biochemical Markers of Bone Turnover in Osteoporosis

  2000cited by this paper
• Premenopausal equol excretors show plasma hormone profiles associated with lowered risk of breast cancer.

  2000cited by this paper
• Markers of Bone Turnover for the Prediction of Fracture Risk

  2000cited by this paper
• Inhibition of dioxin effects on bone formation in vitro by a newly described aryl hydrocarbon receptor antagonist, resveratrol.

  2000cited by this paper
• Alcohol, wine, and health

  2000cited by this paper
• Prune suppresses ovariectomy-induced hypercholesterolemia in rats.

  2000cited by this paper
• Daidzein is more efficient than genistein in preventing ovariectomy-induced bone loss in rats.

  2000cited by this paper
• Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women.

  2000cited by this paper
• Provocative relation between soy and bone maintenance.

  2000cited by this paper
• Prevention of postmenopausal osteoporosis with oestrogen replacement therapy and associated compounds: update on clinical trials since 1995.

  2000cited by this paper
• Vasomotor Symptom Relief by Soy Isoflavone Extract Tablets in Postmenopausal Women: A Multicenter, Double‐Blind, Randomized, Placebo‐Controlled Study

  2000cited by this paper
• Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women.

  2000cited by this paper
• Androgen Deficiency Induces High Turnover Osteopenia in Aged Male Rats: A Sequential Histomorphometric Study

  2000cited by this paper
• Clinical Effects of a Standardized Soy Extract in Postmenopausal Women: A Pilot Study

  2000cited by this paper
• Effect of Soy Protein on Bone Metabolism in Postmenopausal Japanese Women

  2000cited by this paper
• Effect of alcohol intake on bone mineral density in elderly women: The EPIDOS Study. Epidémiologie de l'Ostéoporose.

  2000cited by this paper
• Ipriflavone, a Synthetic Phytoestrogen, Enhances Intestinal Calcium Transport In Vitro

  2000cited by this paper
• Interindividual Variation in Metabolism of Soy Isoflavones and Lignans: Influence of Habitual Diet on Equol Production by the Gut Microflora

  2000cited by this paper
• Bone markers in clinical practice.

  1999cited by this paper
• Repair of segmental bone defects in the rat: an experimental model of human fracture healing.

  1999cited by this paper
• Ethnic, Anthropometric, and Lifestyle Associations with Regional Variations in Peak Bone Mass

  1999cited by this paper
• Expression and Localization of Estrogen Receptor‐β in Murine and Human Bone

  1999cited by this paper
• Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women.

  1999cited by this paper
• Phytoestrogens: the "natural" selective estrogen receptor modulators?

  1999cited by this paper
• Urinary disposition of the soybean isoflavones daidzein, genistein and glycitein differs among humans with moderate fecal isoflavone degradation activity.

  1999cited by this paper
• The two phyto-oestrogens genistein and quercetin exert different effects on oestrogen receptor function

  1999cited by this paper
• The effect of various hormonal preparations and calcium supplementation on bone mass in early menopause. Is there a predictive value for the initial bone density and body weight?

  1999cited by this paper
• Predicting bone loss and fracture risk with biochemical markers: A review.

  1999cited by this paper
• Interim Report and Recommendations of the World Health Organization Task-Force for Osteoporosis

  1999cited by this paper
• Isoflavones and postmenopausal bone health: a viable alternative to estrogen therapy?

  1999cited by this paper
• Dietary soybeans intake and bone mineral density among 995 middle-aged women in Yokohama.

  1999cited by this paper
• Legumes and soybeans: overview of their nutritional profiles and health effects.

  1999cited by this paper
• Biphasic Effects of Genistein on Bone Tissue in the Ovariectomized, Lactating Rat Model

  1998cited by this paper
• The Phytoestrogen Genistein Reduces Bone Loss in Short-Term Ovariectomized Rats

  1998cited by this paper
• Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density-lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women.

  1998cited by this paper
• Japanese intake of flavonoids and isoflavonoids from foods.

  1998cited by this paper
• Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-E1 cells.

  1998cited by this paper
• Bone-sparing effect of soy protein in ovarian hormone-deficient rats is related to its isoflavone content.

  1998cited by this paper
• Phyto-oestrogen excretion and rate of bone loss in postmenopausal women

  1998cited by this paper
• A Unitary Model for Involutional Osteoporosis: Estrogen Deficiency Causes Both Type I and Type II Osteoporosis in Postmenopausal Women and Contributes to Bone Loss in Aging Men

  1998cited by this paper
• Falls Among Community‐Dwelling Elderly in Japan

  1998cited by this paper
• Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast.

  1998cited by this paper
• Genetic control of gonadal differentiation.

  1998cited by this paper
• Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women.

  1998cited by this paper
• Effects of dietary phytoestrogens in postmenopausal women.

  1998cited by this paper
• Soy Protein Isolate Diet Does Not Prevent Increased Cortical Bone Turnover in Ovariectomized Macaques

  1998cited by this paper
• Role of soy protein with normal or reduced isoflavone content in reversing bone loss induced by ovarian hormone deficiency in rats.

  1998cited by this paper
• Phenolic composition and antioxidant activity of prunes and prune juice (Prunus domestica)

  1998cited by this paper
• Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor.

  1997cited by this paper
• Osteoporotic fracture rate, bone mineral density, and bone metabolism in Taiwan.

  1997cited by this paper
• Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study.

  1997cited by this paper
• Incidence rates of falls among Japanese men and women living in Hawaii.

  1997cited by this paper
• Exposure of infants to phyto-oestrogens from soy-based infant formula.

  1997cited by this paper
• Hip fracture incidence among elderly Asian-American populations.

  1997cited by this paper
• Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women.

  1997cited by this paper
• Fracture Healing in a Rat Osteopenia Model

  1997cited by this paper
• Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis.

  1996cited by this paper
• Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats.

  1996cited by this paper
• Do variations in hip geometry explain differences in hip fracture risk between japanese and white americans?

  1994cited by this paper
• Evaluation of the effect of soybean milk and soybean milk peptide on bone metabolism in the rat model with ovariectomized osteoporosis.

  1994cited by this paper
• The bone‐remodeling transient: Implications for the interpretation of clinical studies of bone mass change

  1994cited by this paper
• Animal models for the study of bone loss after cessation of ovarian function.

  1993cited by this paper
• Hip fracture rates in Hong Kong and the United States, 1988 through 1989.

  1993cited by this paper
• Commonly occurring plant flavonoids have estrogenic activity.

  1993cited by this paper
• Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group.

  1993cited by this paper
• Comparison of Osteoporosis and Calcium Intake between Japan and the United States

  1992cited by this paper
• A comparison of hip fracture incidence among native Japanese, Japanese Americans, and American Caucasians.

  1991cited by this paper
• Comparative epidemiology of cancer between the united states and japan. A second look

  1991cited by this paper
• The phytoestrogens present in de-ethanolized bourbon are biologically active: a preliminary study in a postmenopausal woman.

  1991cited by this paper
• The ovariectomized rat model of postmenopausal bone loss.

  1991cited by this paper
• The aged rat model of ovarian hormone deficiency bone loss.

  1989cited by this paper
• Ethnic and genetic differences in bone mass: a review with a hereditary vs environmental perspective.

  1989cited by this paper
• Modulation of age-related hyperparathyroidism and senile bone loss in Fischer rats by soy protein and food restriction.

  1988cited by this paper
• Tamoxifen inhibits osteoclast-mediated resorption of trabecular bone in ovarian hormone-deficient rats.

  1988cited by this paper

• No citing papers are available for this paper.